Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
84pct
116d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Tackling Excessive Standardized Testing Act of 2015 or the TEST Act of 2015 This bill amends the Elementary and Secondary Education Act of 1965 to lower the frequency with which students must take the tests used to determine whether they are making adequate yearly progress (AYP) toward state academic achievement standards in mathematics and reading or language arts. Under current law, students must take such tests in both subjects in each of grades 3 through 8. The bill maintains testing in grades 3 through 8 but authorizes a public school to limit testing: (1) in mathematics, to even-numbered grades or, if the school is at the 15th percentile or above for mathematics in the state or its students are making appropriate progress toward state mathematics achievement standards, to grades 4 and 8 only; and (2) in reading or language arts, to odd-numbered grades or, if the school is at the 15th percentile or above for reading or language arts or its students are making appropriate progress toward state reading or language arts achievement standards, to grades 3 and 7 only. Limited English proficient students who are in their first 12 months of enrollment in a public school are excluded from the determination as to whether students are making AYP toward state academic achievement standards.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2016 · fourth_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Referred to the Subcommittee on Early Childhood, Elementary, and Secondary Education.
Referred to the House Committee on Education and the Workforce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · third_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · second_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · first_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2015 · fourth_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406.
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2015 · fourth_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
Client expense: $170,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2015 · third_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
Client expense: $170,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2015 · second_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
Client expense: $170,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2015 · first_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
Client expense: $170,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2015 · first_quarter · Health Issues
HR3204 Drug Quality & Security Act regarding 3PL licensing & serialization standards and federal licensing of 3PLs. PL-111-148 Patient Protection Affordable Care Act relating to transitional reinsurance and excise tax. 21st Century Cures (Medical Device Licensing Act of 2015) to enact federal licensing for 3PL and wholesale distribution of medical devices in the US. HR2 Medicare Access and CHIP Reauthorization Act of 2015 seeking multi-year funding for the Special Diabetes Program.
Client expense: $3,019,712 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Postal Regulatory Commission, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office